Resonate Recordings https://resonaterecordings.com © 2026 Perspectives by the Leerink Center for Pharmacoeconomics The Leerink Center for Pharmacoeconomics en-us Sat, 25 Apr 2026 11:42:09 +0000 Sat, 25 Apr 2026 11:42:09 +0000 https://storage.googleapis.com/com-resonaterecordings-public/cover-art/aZTTPD5fmGjPzLjOLwbLXWoikBLkZBGvZZfkwzUD.jpg The Leerink Center for Pharmacoeconomics false episodic The Leerink Center for Pharmacoeconomics The Leerink Center for Pharmacoeconomics growthentialpodcast@gmail.com No false 16 What’s Behind Drug Pricing: The Hidden Role and Limits of Cost-Effectiveness Analysis In this episode of Perspectives by the Leerink Center for Pharmacoeconomics, Melanie Whittington breaks down a fundamental—and increasingly consequential—question in health economics: what counts a... full fe6598e4-4c4e-4025-9bdf-57de6e5b3de8 Tue, 31 Mar 2026 17:30:00 +0000 2363 false false 15 Making Value Propositions Clearer with Peter Kolchinsky, PhD, Founder and Managing Partner, RA Capital Management Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, talks with Peter Kolchinsky, PhD, Founder and Managing Partner of RA Capital Management, to discuss if the U.S. market-ba... full 63f355ef-c53d-481b-a351-579644788b02 Mon, 02 Mar 2026 18:00:00 +0000 false false 14 Specialty Drug Coverage Predictions with James Chambers, PhD, MPharm, Professor of Medicine, CEVR, Tufts Medical Center Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews James Chambers, PhD, MPharm, Professor of Medicine in the Center for the Evaluation of Value and Risk in Healt... full 80c3702c-b00c-442c-85c6-a34a09a2f012 Mon, 02 Feb 2026 18:30:00 +0000 2171 false false 13 The National Pharmaceutical Council President and CEO & Former Trump Drug Pricing Advisor, John O'Brien, PharmD, MPH Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, talks with John M. O'Brien, PharmD, MPH, President and CEO of the National Pharmaceutical Council & Former Trump Drug Pri... full 6cf316cd-28ce-4959-9c75-b2ec83590402 Thu, 08 Jan 2026 22:10:00 +0000 2271 false false 12 David Hong, MD, Steve Potts, PhD, MBA, and Vivek Subbiah, MD talk Pan-Tumor Approvals in a Post-IRA World Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, talks with Vivek Subbiah, MD, David Hong, MD, and Steve Potts, PhD, MBA to discuss if pan-tumor approval strategies offer a pa... full 84faa8ef-6db2-49db-9fac-d78caa88c4b3 Tue, 02 Dec 2025 19:00:00 +0000 2533 false false 12 Head of the Leerink Center for Pharmacoeconomics, Melanie Whittington, PhD Diane Vieira, Head of Marketing & Communications at Leerink Partners, interviews Melanie Whittington, PhD, Head of the Leerink Center of Pharmacoeconomics (CPE), to discuss the one-year anniversary... full f0e49230-b8cd-4592-91b4-3393993dd08c Mon, 03 Nov 2025 19:00:00 +0000 false false 10 Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Steve Potts, PhD, MBA, CEO and Co-Founder, Stealth Cancer Biotech, to discuss the impact of the Inflation Reduction... full 95962e3a-0dfb-409f-9506-6c3f4596b9b9 Mon, 06 Oct 2025 18:00:00 +0000 false false 9 The IP Policy Institute’s Joshua Kresh and Emily Michiko Morris Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Joshua Kresh and Emily Michiko Morris from The IP Policy Institute at the University of Akron School of Law to disc... full 2974a0eb-acfd-4d4a-b12c-e9f7ee6669fc Mon, 08 Sep 2025 18:00:00 +0000 false false 6 Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews Ulrich Neumann, MBA, MSc, MA, Director of Access and Policy Research at Johnson & Johnson, to discuss the mot... full f8933fec-eac6-4067-86ab-71bc23c40224 Wed, 13 Aug 2025 18:30:00 +0000 false false Head of Patient Engagement and Patient-Centered Innovation, Raven, RA Capital's healthcare incubator, Gunnar Esiason, MBA, MPH Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, talks with Gunnar Esiason, Head of Patient Engagement and Patient-Centered Innovation at Raven, RA Capital's healthcare incuba... full 26a4c511-6009-4594-9c12-345cd6c24596 Mon, 14 Jul 2025 17:30:00 +0000 false false Vice Chair of Research and Associate Professor, University of Utah, Joey Mattingly, PharmD, MBA, PhD Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics, interviews Joey Mattingly, PharmD, MBA, PhD, Vice Chair of Research and Associate Professor at the University of Utah, to... full 8eb5fcfd-6036-4a4b-8833-df403ff2c7c8 Tue, 17 Jun 2025 18:00:00 +0000 false false 5 Chief Science Officer, National Pharmaceutical Council, Jon Campbell, PhD Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics, interviews Jon Campbell, Chief Science Officer of the National Pharmaceutical Council, to discuss what makes biopharmaceutical... full d49756ac-d485-450b-88c8-94406eb5ea96 Wed, 21 May 2025 18:00:00 +0000 2000 false false 4 Head of U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi, Elizabeth Franklin, PhD, MSW Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Elizabeth Franklin, PhD, MSW, Head of U.S. Public Affairs and Patient Advocacy, Oncology with Sanofi where they disc... full 065b4655-76a4-409c-8107-98e5ce3d3a89 Wed, 23 Apr 2025 18:00:00 +0000 2087 false false 3 Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute, Kirsten Axelsen Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Kirsten Axelsen, Senior Policy Advisor at DLA Piper & Non-Resident Fellow at the American Enterprise Institute where... full a9a8e1a6-b2cf-4fa8-9cf8-894d38f1ebd1 Wed, 26 Mar 2025 18:00:00 +0000 1502 false false 2 Managing Director of Pharmagellan and Professor of the Practice at Tufts University, Frank S. David, MD, PhD Melanie Whittington, Head of the Leerink Center for Pharmacoeconomics interviews Frank S. David, MD, PhD, Managing Director of Pharmagellan and Professor of the Practice at Tufts University. The he... full 53a82eb3-f8b4-4e1f-887d-6f343c942ce5 Wed, 26 Feb 2025 19:00:00 +0000 2307 false false 1 Author of the Cost Curve & the Principal and Founder of Reid Strategic, Brian Reid Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics interviews Brian Reid, Author of the Cost Curve & the Principal and Founder of Reid Strategic. In this episode they discus... full e0b4273f-201b-424f-9672-d30d2c49d5f6 Wed, 29 Jan 2025 19:00:00 +0000 1923 false false Welcome to Perspectives by the Leerink Center for Pharmacoeconomics In our signature podcast series, Dr. Mel Whittington, a health economist and Head of the Leerink Center for Pharmacoeconomics, talks with people from across the industry to hear their stories and t... trailer dc501bcf-66de-41db-accb-75841a833139 Mon, 06 Jan 2025 10:00:00 +0000 52 false false